TOP TIERMARKET NEWSWIRE
News & sentiment

ZENTALIS PHARMACEUTI (ZNTL) — News & AI sentiment

ZENTALIS PHARMACEUTI (ZNTL) news roundup. 1 story in the last 24 hours, 1 in the past week, 3 over 30 days. Average 24-hour sentiment is 50/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 50/100
7d stories
1
avg sentiment 50/100
30d stories
3
avg sentiment 56.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on ZNTL

5h ago
Rodman & Renshaw initiates Zentalis stock with buy on drug potential
Investing.com Analyst Ratings61 · neutralanalyst
Jul 23
Jul 17
Jun 18
Jun 1
May 27
May 27
May 21
May 21
Open ZNTL in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →